Delineating Amyloid Plaque Associated Neuronal ... - ACS Publications

Dec 16, 2016 - Special Issue: Monitoring Molecules in Neuroscience 2016. Received: November 14, 2016. Accepted: December 16 .... software (Figure S-1D...
2 downloads 13 Views 1MB Size
Subscriber access provided by GAZI UNIV

Article

Delineating Amyloid Plaque Associated Neuronal Sphingolipids In Transgenic Alzheimer’s Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry Ibrahim Kaya, Dimitri Brinet, Wojciech Michno, Stina Syvanen, Dag Sehlin, Henrik Zetterberg, Kaj Blennow, and Jörg Hanrieder ACS Chem. Neurosci., Just Accepted Manuscript • DOI: 10.1021/acschemneuro.6b00391 • Publication Date (Web): 16 Dec 2016 Downloaded from http://pubs.acs.org on December 18, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

ACS Chemical Neuroscience is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 23

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

1

Delineating Amyloid Plaque Associated Neuronal Sphingolipids in

2

transgenic Alzheimer’s Disease Mice (tgArcSwe) Using MALDI

3

Imaging Mass Spectrometry

4

Ibrahim Kaya1#, Dimitri Brinet1,2#, Wojciech Michno1, Stina Syvänen3, Dag Sehlin3,

5

Henrik Zetterberg1,4,5, Kaj Blennow1,4, and Jörg Hanrieder1,5,6

6

1

7

Gothenburg, Mölndal, Sweden

8

2

Department of Chemistry and Molecular Biology, University of Gothenburg, Sweden

9

3

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden

10

4

Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden

11

5

Department of Molecular Neuroscience, UCL Institute of Neurology, University College

12

London, UK

13

6

14

Gothenburg, Sweden

Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of

Department of Chemistry and Chemical Engineering, Chalmers University of Technology,

15

16 17

Corresponding Author:

18

Jörg Hanrieder, PhD

19

Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of

20

Gothenburg, Mölndal Hospital, House V, Biskopsbogatan 27, SE-43180 Mölndal, Sweden

21

[email protected]; +46-31-343 2377

22

23

1 Environment ACS Paragon Plus

ACS Chemical Neuroscience

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 23

24

ABSTRACT

25

The major pathological hallmarks of Alzheimer’s disease (AD) are the progressive

26

aggregation and accumulation of beta-amyloid (Aβ) and hyperphosphorylated tau protein into

27

neurotoxic deposits. Aβ aggregation has been suggested as the critical early inducer, driving

28

the disease progression. However, the factors that promote neurotoxic Aβ aggregation

29

remain

30

comprehensively elucidate the spatial distribution patterns of lipids, peptides and proteins in

31

biological tissue sections. In the present study, matrix-assisted laser desorption/ionization

32

(MALDI) mass spectrometry (MS)-based imaging was used on transgenic Alzheimer’s

33

disease mouse (tgArcSwe) brain tissue to investigate the sphingolipid microenvironment of

34

individual Aβ plaques and elucidate plaque-associated sphingolipid alterations. Multivariate

35

data analysis was used to interrogate the IMS data for identifying pathologically relevant,

36

anatomical features based on their lipid chemical profile. This approach revealed sphingolipid

37

species that distinctly located to cortical and hippocampal deposits, whose Aβ identity was

38

further verified using fluorescent amyloid staining and immunohistochemistry. Subsequent

39

multivariate statistical analysis of the spectral data revealed significant localization of

40

gangliosides and ceramides species to Aβ positive plaques, which was accompanied by

41

distinct local reduction of sulfatides. These plaque-associated changes in sphingolipids levels

42

implicate a functional role of sphingolipid metabolism in Aβ plaque pathology and AD

43

pathogenesis. Taken together, the presented data highlight the potential of imaging mass

44

spectrometry as a powerful approach for probing Aβ plaque-associated lipid changes

45

induced by AD neuropathology.

elusive.

Imaging

mass

spectrometry

(IMS)

is

a

powerful

technique

to

46

47

Keywords: Alzheimer’s disease, Amyloid-β plaque pathology, MALDI Imaging mass

48

spectrometry, sphingolipids, tgArcSwe.

49

2 Environment ACS Paragon Plus

Page 3 of 23

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

50

INTRODUCTION

51

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder. The

52

neuropathology of AD is characterized by the formation of protein deposits in the brain

53

including intercellular neurofibrillary tangles consisting of hyper-phosphorylated tau protein1

54

and extracellular plaques formed by aggregated amyloid-β (Aβ) peptides

55

rapidly aggregate to oligomers, protofibrils and fibrils, eventually leading to formation of

56

extracellular plaques. Little is known about the molecular mechanisms of how monomeric Aβ

57

peptides are converted to neurotoxic, aggregated forms that are rich in β-sheet motifs. A

58

number of biochemical and clinical studies suggest that in addition to peptide centric

59

mechanisms, changes in neuronal lipid metabolism may be implicated in AD pathogenesis

60

and plaque pathology in particular.4,

61

apolipoprotein E (APOE) ε4 allele, a lipid transporter protein, was identified as the major risk

62

factor to develop sporadic AD, further suggesting a possible role for lipids in AD

63

pathogenesis6-9. Hence, several studies on the relevance of neuronal lipid species

64

associated with AD pathology, including sphingolipids10, 11, cholesterol12 and phospholipids13

65

have been reported. In particular, a potential role in AD pathogenesis has been suggested

66

for a number of sphingolipid species, including ceramides7,

67

gangliosides16-19. Therefore, in order to further delineate the relevance of sphingolipids in AD

68

pathogenesis, it is important to outline their spatial distribution profile in situ. Genetically

69

altered mouse models are of central relevance to probe the molecular mechanisms of AD

70

pathology.20, 21 For instance, a transgenic mouse model of AD, with mice carrying both the

71

Arctic (E693G) and the Swedish (K670M/N671L) mutations (tgArcSwe) of amyloid precursor

72

protein (APP) has been developed. These mice exhibit in extensive Aβ deposition with an

73

onset at the age of 5–6 months, and are a well-suited model system to study molecular

74

mechanisms for Aβ deposition.22

75

In order to characterize disease pathology in situ, advanced molecular imaging techniques

76

are required including imaging mass spectrometry (IMS). This technique is often referred as

5

2, 3

. Aβ peptides

Furthermore, genetic predisposition with the

3 Environment ACS Paragon Plus

14

, sulfatides14,

15

and

ACS Chemical Neuroscience

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 23

77

molecular histology and allows to generate spatial intensity distribution maps of molecular

78

species

79

desorption/ionization (MALDI) based IMS is a well suited IMS modality to probe neuronal

80

lipids24, including gangliosides25 as well as for in situ characterization of endogenous

81

neuropeptides26,

82

IMS, has been previously successfully demonstrated for probing Aβ peptide pathology in

83

tgArcSwe mice.28

84

In

85

microenvironment, including ganglioside-, sulfatide- and ceramide- localizations to cortical

86

and hippocampal Aβ plaques in tgArcSwe mice. Here, IMS was used in conjunction with

87

multivariate statistical analysis (MVSA) tools to identify regional plaque-associated changes

88

in neuronal sphingolipid chemistry.

the

in

complex

27

present

biological

tissues

23

.

In

particular,

matrix

assisted

laser

associated with neurodegenerative disease pathology. Indeed, MALDI-

study,

MALDI-IMS

was

employed

to

examine

the

sphingolipid

89

90

RESULTS AND DISCUSSION

91

MALDI Imaging MS Reveals Distinct Localization of Neuronal Sphingolipid Species on

92

the Cortical and Hippocampal Amyloid-β Plaques

93

In MALDI-IMS, sample preparation includes deposition of a matrix species, dissolved in an

94

aqueous/organic solvent system onto the tissue sections. However, this process can result in

95

lateral analyte diffusion and disturbance of tissue morphology. In contrast, sublimation is a

96

solvent free approach for matrix deposition that overcomes analyte delocalization issues

97

arising with wet matrix application and hence allows for high-spatial resolution

98

sublimation of 1,5-diaminonaphthalene (1,5-DAN) for MALDI IMS was shown to give

99

enhanced signal intensity for neuronal lipid species at high spatial resolution, particularly in 30

29

. Previously,

100

negative ion mode

. In the present study, 1,5-DAN sublimation was therefore used for

101

MALDI-IMS analysis of neuronal sphingolipids in tgArcSwe mice. The acquired image data

102

were investigated by using unsupervised multivariate statistics based on hierarchical

4 Environment ACS Paragon Plus

Page 5 of 23

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

103

clustering analysis (bisecting k-means) in order to obtain image segmentation of anatomical

104

regions of interest based on their lipid chemical profile. Here, image segmentation identified

105

deposit-like features in the cortex and hippocampus (Figure 1A,B). These features were

106

assigned as individual regions of interest (ROI) and correlated to the processed MS data, in

107

order to identify the associated chemical species that allowed image segmentation of the

108

regions.

109 110 111 112 113 114 115 116 117 118 119 120 121 122 123

Figure 1. Multivariate image analysis of MALDI-IMS data reveals cortical and hippocampal sphingolipid accumulations in tgArcSwe mouse brain. (A) Bright field image showing dorsolateral part of a coronal section used for IMS analysis. Anatomical regions wre annotated including: Ctx cortex, WM white matter, LV lateral ventricle, hipp hippocampus, DG dentate gyrus of the hippocampus. (B) Segmentation map obtained from multivariate image analysis of the MALDI-IMS data. Bisecting k-means based hierarchical clustering analysis identified plaque-like features (green, yellow, orange) in the cortex and hippocampus based on the encoded chemical information. Inspection of the associated variables (m/z values) expressing the clustering behavior, revealed m/z values localizing to anatomical features. (C) This includes e.g. Cer(d18:1/12:0) at m/z 480.5 as further verified by the corresponding single ion image as a representative plaque associate sphingolipid species. Scale bar = 0.5 mm.

124

species to the plaque-like features, including ceramides and gangliosides. Visualization of

125

single ion intensity distributions (i.e. single ion images) for the individual ceramide- (e.g.

126

Cer(d18:1/12:0), m/z 480.5, Figure 1C) and ganglioside species (Figure 4) showed a

Inspection of the corresponding variables revealed localization of various sphingolipid

5 Environment ACS Paragon Plus

ACS Chemical Neuroscience

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 23

127

consistent deposit-like distribution patterns throughout the cortical and hippocampal regions.

128

Hence, the here employed workflow for unbiased segmentation of the complex imaging data

129

was found to be a strong approach for elucidating the chemical composition of the plaque-

130

like deposits.

131

132

Amyloid-β

Plaque

Identification

and

Validation

by

Subsequent

Fluorescent

133

Histochemical Amyloid Staining

134

In order to verify the potential plaque identity as observed for individual ceramide- and

135

ganglioside accumulations, including e.g. Cer(d18:1/12:0) (Figure 2A, B), histochemical

136

staining was performed using a luminescent conjugated oligothiophene (LCO), h-FTAA, a

137

fluorescent amyloid probe (Figure 2C)

138

amyloid staining and distributions profiles of distinct sphingolipid species as identified by

139

MALDI-IMS (Figure 2D). Furthermore, in order to confirm the specificity of the chemical

140

amyloid staining to Aβ fibrils, double staining of h-FTAA and Aβ immunohistochemistry (IHC)

141

was performed using a monoclonal Aβ antibody (Aβ1-16, 6E10). The fluorescent imaging

142

results show clear double positive staining of the plaques for both h-FTAA and Aβ, thereby

143

confirming the Aβ identity of the h-FTAA stained deposits (Suppl. Figure S-1A-C).

31

. Here, a strong co-localization was observed for

6 Environment ACS Paragon Plus

Page 7 of 23

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

144 145

Figure 2. Identification of Aβ deposits localized with MALDI-IMS using fluorescent

146

amyloid staining. (A) Single ion image of m/z 480.5 (Cer(d18:1/12:0)) using MALDI-IMS

147

with 10 µm spatial resolution. (B) Magnified single ion images of m/z 480.5 from the cortex.

148

(C) Histologically identified plaque, stained with h-FTAA reveals Aβ fibril structures in the

149

cortical regions (D) co-localized with the accumulation observed in the magnified single ion

150

images of m/z 480.5. Scale bars A=400 µm, B-D= 100 µm.

151

152

In addition, to further verify the lipid localizations to amyloid plaques, a bottom up

153

multivariate, correlation analysis approach was used. Here, both imaging MS data and

154

fluorescent staining data (h-FTAA and IHC) were co-registered in the SciLs software (Suppl.

155

Figure S-1D,E). This was followed by annotation of h-FTAA/Aβ double positive features in

156

the fluorescence imaging data and correlation analysis to the whole imaging data set. The

157

results revealed the most prominent variables (m/z values) that correlate with Aβ and h-

158

FTAA double positive plaque regions (Suppl. Figure S-1D,E). Here, the most significant

159

peaks above a certain threshold at p